Adverse effects of observational studies when examining adverse outcomes of drugs: case-control studies with low prevalence of exposure
Austin PC, Mamdani M, Williams JI. Drug Saf. 2002; 25(9):677-87.
Austin PC, Mamdani M, Williams JI. Drug Saf. 2002; 25(9):677-87.
Rhodes AE, Goering PN, To T, Williams JI. Soc Sci Med. 2002; 54(1):1-10.
Chan B. Hosp Q. 2001; 5(2):25-6.
Coyte PC, Croxford R, Asche CV, To T, Feldman W, Friedberg J. JAMA. 2001; 286(17):2128-35.
Jaakkimainen L. Hosp Q. 2001; 5(1):17.
Ferris LE, Shulman KL, Williams JI. Can J Program Eval. 2001; 16(2):27-40.
Bell CM, Redelmeier DA. N Engl J Med. 2001; 345(9):663-8.
Sin DD, Tu JV. Am J Respir Crit Care Med. 2001; 164(4):580-4.
Crighton EJ, Mamdani MM, Upshur RE. BMC Health Serv Res. 2001; 1:7. Epub 2001 Aug 10.
Clarke HF, Laschinger HS, Giovannetti P, Shamian J, Thomson D, Tourangeau A. Hosp Q. 2001; 4(4):50-7.